Delivering support through every stage of the pharmaceutical lifecycle

As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle. As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle. ... Read more

Molecule lifecycle services at Sterling

With the rising complexity of APIs in the pipeline today, complete project continuity has become increasingly critical to proactively address challenges, enhance efficiency, minimise costs, streamline development and manufacturing, and accelerate time to market. As a result, pharmaceutical and biotechnology organisations require an outsourced partner with the capabilities to support their product throughout its entire lifecycle, from grams to tonnes.

As a full service PDMO, or partnership development and manufacturing organisation, we have extensive expertise supporting our customers’ molecules from the earliest phases of discovery through to full commercial manufacture. In our global delivery network, our customers will find the world-class facilities, specialised equipment, and highly skilled team members they need to address a wide range of project requirements at every stage—all while benefiting from our simple way of working, our commitment to integrity, and our true scientific collaboration. Read less

Here’s how we accelerate your product’s path to market by delivering unrivalled support at every stage of the pharmaceutical lifecycle.

As many drugs in the pipeline fail to progress past phase II trials, phase III is a significant milestone for our customers and their products. In this critical phase, we work to finalise data generation and process validation, and to prepare in earnest for full commercial manufacture. Scale, efficiency, quality control, integrity, and compliance are all top priorities as we navigate the last phase prior to commercial launch.

Technologies & Services

Knowledge Hub Articles

Phase Three: Molecule Lifecycle Brief

An overview of Sterling Pharma Solutions

Environmental sustainability in the pharmaceutical industry

Full-lifecycle sustainability

High Potency APIs are on the rise

Making sense of regulatory requirements

Making Sense of Hazard Evaluation

Making sense of the pharmaceutical supply chain

Material Science at Sterling

OncoTEX and Sterling sign clinical manufacturing agreement for development of novel treatment against ovarian cancer

Passion: What makes a PDMO?

Science: What makes a PDMO?

Scientist Snapshot: Director of CMC, Chris Seekamp

Service: What makes a PDMO?

Sterling partners with Newcastle University to offer PhD project

Sterling Pharma Solutions acquires Alcami Germantown facility in US

Sterling: A journey with Chromeleon CDS

What is a PDMO?

Your Chromatography Data System – are you in control?

Service. Passion. Science.